Journal of Diabetes Research (Jan 2024)

Preoperative Intravitreal Conbercept Injection Reduced Both Angiogenic and Inflammatory Cytokines in Patients With Proliferative Diabetic Retinopathy

  • Zijing Huang,
  • Li Jia Chen,
  • Dingguo Huang,
  • Jingsheng Yi,
  • Zhiying Chen,
  • Peimin Lin,
  • Yifan Wang,
  • Jianlong Zheng,
  • Weiqi Chen

DOI
https://doi.org/10.1155/2024/2550367
Journal volume & issue
Vol. 2024

Abstract

Read online

Conclusions: Intravitreal conbercept injection presents dual effects of antiangiogenesis and anti-inflammation and can be served as an adjuvant treatment to vitrectomy for PDR patients.